GT Biopharma CEO, Tony Cataldo to Present at Sir Anthony Ritossa’s Global Family Office Investment Summit

BEVERLY HILLS, Calif: BEVERLY HILLS, Calif, June 24, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, today announced that GT...

Click to view original post